Steroid sulfatase inhibitors for estrogen- and androgen-dependent cancers
about
The Regulation of Steroid Action by Sulfation and DesulfationAndrogens in pregnancy: roles in parturitionThe structural biology of oestrogen metabolismAnalysis of estrogens and androgens in postmenopausal serum and plasma by liquid chromatography-mass spectrometry.Ultrasensitive quantification of serum estrogens in postmenopausal women and older men by liquid chromatography-tandem mass spectrometry.PAPSS2 deficiency causes androgen excess via impaired DHEA sulfation--in vitro and in vivo studies in a family harboring two novel PAPSS2 mutations.Induction of Integrin Signaling by Steroid Sulfatase in Human Cervical Cancer Cells.Genetic and pharmacological modulation of the steroid sulfatase axis improves response control; comparison with drugs used in ADHD.Estrogen biosynthesis and action in ovarian cancer.Hormone metabolism pathway genes and mammographic density change after quitting estrogen and progestin combined hormone therapy in the California Teachers StudyMechanisms of drug resistance that target the androgen axis in castration resistant prostate cancer (CRPC).The sulfatase pathway for estrogen formation: targets for the treatment and diagnosis of hormone-associated tumors.Human 3β-hydroxysteroid dehydrogenase type 1 in human breast cancer: clinical significance and prognostic associations.Molecular pathways: Inhibiting steroid biosynthesis in prostate cancer.Phase two steroid metabolism and its roles in breast and prostate cancer patientsBacterial Lipopolysaccharides Induce Steroid Sulfatase Expression and Cell Migration through IL-6 Pathway in Human Prostate Cancer Cells.Sulfatase inhibitors: a patent review.Ultra-high sensitivity analysis of estrogens for special populations in serum and plasma by liquid chromatography-mass spectrometry: Assay considerations and suggested practices.Design, synthesis, and biological evaluation of new arylamide derivatives possessing sulfonate or sulfamate moieties as steroid sulfatase enzyme inhibitorsClinical implications of estrone sulfate measurement in laboratory medicine.Overcoming aromatase inhibitor resistance in breast cancer: possible mechanisms and clinical applications.Role of OATP transporters in steroid uptake by prostate cancer cells in vivo.Effect of estrogen sulfation by SULT1E1 and PAPSS on the development of estrogen-dependent cancers.Human steroid sulfatase induces Wnt/β-catenin signaling and epithelial-mesenchymal transition by upregulating Twist1 and HIF-1α in human prostate and cervical cancer cells.Sex-Dependent Role of Estrogen Sulfotransferase and Steroid Sulfatase in Metabolic Homeostasis.Clinical relevance of hypercoagulability and possible hypofibrinolysis associated with estrone and estriol.Steroidal Pyrimidines and Dihydrotriazines as Novel Classes of Anticancer Agents against Hormone-Dependent Breast Cancer Cells.Possible role of the aromatase-independent steroid metabolism pathways in hormone responsive primary breast cancers.Intracrine Regulation of Estrogen and Other Sex Steroid Levels in Endometrium and Non-gynecological Tissues; Pathology, Physiology, and Drug Discovery
P2860
Q26799364-4BEA34F3-ED27-43C2-86C9-714463CB007DQ26822669-E2A68B2A-1175-4677-A77F-F3620F7E36D0Q27009283-8DDE23DD-A55B-433F-ACD2-9F5D5AE8C364Q30358054-EE21ABF3-B055-4808-A093-B56383E8CB95Q30360030-041506D6-B1FE-403B-A403-5509FAE06611Q30408472-83B7C337-4390-4DF6-8D35-2B29B7E391CBQ33655922-339B376C-C512-4977-90B7-5AAECCB5770AQ34075473-58768B25-552C-4E38-B2D4-43802A0859E3Q34496401-31F5C740-E8A5-4508-8024-2FD419D3ED69Q35052877-0F9740DA-AFC2-4BA7-A7FF-6697F73B52ABQ36055229-E6DEFFD2-4490-49CF-90B6-0919C42FC72FQ36651350-B369BBD5-7042-4273-80D1-B7D96D3530B0Q36892987-FDA1E947-6DCB-4184-A1F6-E7C8B1DDBD34Q37076775-20996E78-0F8F-464D-ABD9-00BD148BDF89Q37142561-CC195A62-D9CF-457B-BE86-A76584B5A595Q37145415-22DA5671-C7E4-47F1-9AC0-E7FC8FDCCF54Q38058531-8771BB1D-B01A-4179-9FA2-103AD84F08B9Q38696577-84FFABEB-4293-4591-A8BB-672FBA5A9765Q38773372-A5CBA770-BE59-4359-942A-7904CE10BF58Q39037694-A93E8B7C-9D73-4819-A16A-917E054F7D0DQ39227889-9ADFA8BD-B07C-491E-AAC5-B9BBA65E441CQ39373966-B0AF2817-6B84-4A86-82EE-18B0B690A510Q39387598-3D2AEDF0-C51E-4728-A52D-BF31321D6D00Q42365286-958BEBBF-F2E9-4832-9670-FEAD8DA8735FQ46244503-C367FFD3-C162-49B7-A279-C8C77069E094Q46351724-733E64FE-EF00-468E-9EC8-557FA8DF4BBDQ49268662-4CB519F2-2252-4C20-AE47-1E85F3869DDEQ50467757-635CCFA6-C572-4B69-A8C8-DA7E335C9A86Q57072939-F39D87EB-EA5E-4125-B973-8EDC73F2554F
P2860
Steroid sulfatase inhibitors for estrogen- and androgen-dependent cancers
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Steroid sulfatase inhibitors for estrogen- and androgen-dependent cancers
@ast
Steroid sulfatase inhibitors for estrogen- and androgen-dependent cancers
@en
Steroid sulfatase inhibitors for estrogen- and androgen-dependent cancers
@nl
type
label
Steroid sulfatase inhibitors for estrogen- and androgen-dependent cancers
@ast
Steroid sulfatase inhibitors for estrogen- and androgen-dependent cancers
@en
Steroid sulfatase inhibitors for estrogen- and androgen-dependent cancers
@nl
prefLabel
Steroid sulfatase inhibitors for estrogen- and androgen-dependent cancers
@ast
Steroid sulfatase inhibitors for estrogen- and androgen-dependent cancers
@en
Steroid sulfatase inhibitors for estrogen- and androgen-dependent cancers
@nl
P3181
P356
P1476
Steroid sulfatase inhibitors for estrogen- and androgen-dependent cancers
@en
P2093
A. Purohit
P304
P3181
P356
10.1530/JOE-11-0266
P407
P50
P577
2012-02-01T00:00:00Z